← Leaderboards
Kay O Broschat
Nupeak Therapeutics, Inc.
$2,038,199
Attributed
$2,038,199
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$2,038,199 · 1
By mechanism
R42$2,038,199 · 1
Top collaborators
No co-investigators on record.
Most similar at Nupeak Therapeutics, Inc.
Same institution · by research overlap
- Michael J Holtzman$600,000
Others in their field
Other Rising Stars on “Airway Disease”
- Songthip T. Ounpraseuth · Univ Of Arkansas For Med Scis$10,363,762
- Jeff T Hutchins · Inhalon Biopharma, Inc.$8,735,864
- Erica Anderson$6,734,645
- Riccardo Gottardi · Children'S Hosp Of Philadelphia$3,716,467
- Julien Papillon · University Of Texas Med Br Galveston$3,556,177
- David T. Kent · Vanderbilt University Medical Center$3,120,041
Research focus
Airway DiseaseAirway InflammationAllergensAnimal ModelAnimal SafetyAntibodiesAsthmaAttributes Of ChemicalsAwardBasal CellBindingBiological MarkersBiotechnologyCanis FamiliarisCell GrowthCell ModelCell ReprogrammingCellsChemistryChronic Obstructive Pulmonary DiseaseClinical TrialsClinical Trials DesignCommercializationAdrenal Cortex Hormones